[α]D Ϫ17.27 (c 0.75, CHCl3); RF 0.24 (silica, ethyl acetate);
λmax(MeOH)/nm 208 and 285; νmax(film)/cmϪ1 3244, 1646, 1447
and 755; δH(CDCl3) 1.88 (m, 2H, CH2CH2N), 2.15 (m, 1H,
CHCH2CH2N), 2.70 (m, 1H, CHCH2CH2N), 2.95 [dd, J 16.5,
10.0, 1H, C(O)CH2], 3.14 [dd, J 16.5, 3.7, 1H, C(O)CH2], 3.61
(m, 2H, CH2N), 4.62 (dd, J 7.5, 6.2, 1H, CHCH2CH2CH2N),
4.94 (dt, J 10.0, 3.7, 1H, CHPh), 6.09 (s, 1H, NH) and 7.26–
7.43 (m, 5H, Ph); δC(CDCl3) 23.32, 29.16, 44.05, 48.46, 53.80,
58.42, 126.81, 129.45, 129.94, 139.81, 168.16 and 171.02; m/z
(EI) 244 (Mϩ) [Found (HRMS, EI): m/z 244.1207. Calc. for
C14H16O2N2: 244.1212].
J 7.7, 3.3, 1H, CHCH2CH2CH2N), 6.14 (s, 1H, NH), 6.85 (s,
1H, NH) and 7.27–7.63 (m, 5H, Ph); δC(CDCl3) 21.73, 24.94,
28.71, 47.98, 50.28, 60.49, 69.91, 127.64, 129.27, 129.59, 136.41,
171.93 and 174.26; m/z (FAB) 357 (Mϩ ϩ 1) (Found: C, 50.43;
H, 5.92; N, 7.54. Calc. for C15H20N2O3Se: C, 50.71; H, 5.67; N,
7.88%).
(S)-N-(3-Hydroxy-2-phenylselenobutanoyl)prolinamide 11
Mp 56–59 ЊC; [α]D Ϫ69.29 (c 0.89, CHCl3); RF 0.07 (silica, ethyl
acetate); νmax(film)/cmϪ1 3360, 3200, 2975, 2880, 1680, 1626,
1428 and 739; δH(CDCl3) 1.43 (d, J 6.3, 3H, CH3), 1.87–1.99 (m,
3H, CHCH2CH2N), 2.34 (m, 1H, CHCH2CH2N), 3.41 (m, 2H,
CH2N), 3.59 (d, J 7.8, 1H, HCSePh), 3.87 (1H, br s, OH), 4.23
(m, 1H, CHCH3), 4.59 (m, 1H, CHCH2CH2CH2N), 5.70 (s, 1H,
NH), 6.73 (s, 1H, NH) and 7.28–7.65 (m, 5H, Ph); δC(CDCl3)
21.14, 25.25, 27.74, 47.94, 49.28, 59.93, 69.07, 126.28, 129.42,
129.70, 136.54, 172.67 and 174.18; m/z (FAB) 357 (Mϩ ϩ 1)
(Found: C, 50.37; H, 5.89; N, 7.56. Calc. for C15H20N2O3Se: C,
50.71; H, 5.67; N, 7.88%).
(S)-N-Crotonylprolinamide 7
This compound was analogously prepared as described for 1;
mp 122–124 ЊC; [α]D Ϫ274.63 (c 1.11, CHCl3); RF 0.1 (silica,
ethyl acetate); νmax(film)/cmϪ1 3299, 3170, 1675, 1606, 1428, 965
and 753; δH(CDCl3) (dd, J 6.9, 1.9, 3H, CH3), 1.97–2.08 (m, 3H,
CHCH2CH2N), 2.37 (m, 1H, CHCH2CH2N), 3.60 (m, 2H,
CH2N), 4.64 (dd, J 8.0, 2.0, 1H, CHCH2CH2CH2N), 6.16 (dd,
J 15.0, 1.9, 1H, CH᎐CHCH ) and 6.96 (dq, J 15.0, 6.9, 1H,
᎐
3
CH᎐CHCH ); δ (CDCl ) 17.84, 24.58, 27.59, 47.08, 59.30,
Acetylation of (S)-N-(3-hydroxy-2-phenylselenobutanoyl)-
prolinamide 10 and 11
᎐
3
C
3
122.27, 142.18, 165.59 and 174.02; m/z (EI) 182 (Mϩ).
The reaction was carried out with acetic anhydride (1.1 equiv.)
and pyridine (1.1 equiv.) in CH2Cl2 to give 12 and 13 as colour-
less oils.
Cyclofunctionalization of (S)-N-crotonoylprolinamide 7
To a solution of (S)-N-crotonoylprolinamide 7 (725 mg, 4.0
mmol) in acetonitrile (50 ml) were added silver trifluorometh-
anesulfonate (3.37 g, 13.1 mmol) in acetonitrile (25 ml), and
then benzeneselenyl bromide (2.82 g, 11.9 mmol) and dimethyl-
formamide (9.2 ml, 119 mmol) in acetonitrile (25 ml). The
resulting mixture was stirred at ambient temperature for 12 h
after which it was treated with saturated aqueous NaHCO3, and
extracted with methylene dichloride. The organic layer was sep-
arated, washed with brine and evaporated to give the crude
product. Column chromatography of this afforded 8 (178.4 mg,
13.2%) and 9 (56 mg, 4.2%) as colourless crystals and 10 (649
mg, 46.9%) and 11 (274.8 mg, 19.4%) as white solids.
(S)-N-(3-Acetoxy-2-phenylselenobutanoyl)prolinamide
12.
[α]D Ϫ144.55 (c 0.855, CHCl3); RF 0.13 (silica, ethyl acetate);
νmax(film)/cmϪ1 3350, 3200, 2990, 1738, 1686, 1636, 1430 and
1237; δH(CDCl3) 1.49 (d, J 6.3, 3H, CHCH3), 1.88 [3H, s,
C(O)CH3], 2.00–2.21 (m, 3H, CHCH2CH2N), 2.33 (m, 1H,
CHCH2CH2N), 3.36–3.71 (m, 2H, CH2N), 4.01 (d, J 9.0, 1H,
HCSePh), 4.46 (dd, J 7.2, 1.8, 1H, CHCH2CH2CH2N), 5.33
(dq, J 9.0, 6.3, 1H, CHCH3), 5.91 (s, 1H, NH), 7.01 (s, 1H, NH)
and 7.28–7.64 (m, 5H, Ph); δC(CDCl3) 18.55, 21.24, 25.14,
27.60, 47.86, 48.72, 60.06, 71.93, 126.30, 129.37, 136.29, 169.97
and 170.24; m/z (FAB) 399 (Mϩ ϩ 1).
(S)-N-(3-Acetoxy-2-phenylselenobutanoyl)prolinamide
13.
(3R,9aS)-3-[(1ЈR)-1Ј-Phenylselenoethyl]-3-methyloctahydro-
pyrrolo[1,2-a][1,4]diazepine-1,5-dione 8
[α]D Ϫ13.12 (c 1.6, CHCl3); RF 0.15 (silica, ethyl acetate);
νmax(film)/cmϪ1 3360, 3200, 2980, 1738, 1686, 1636, 1429, 1238
and 749; δH(CDCl3) 1.55 (d, J 6.3, 3H, CH3), 1.91 [3H, s,
C(O)CH3], 2.00–2.18 (m, 3H, CHCH2CH2N), 2.32 (m, 1H,
CHCH2CH2N), 3.51 (m, 2H, CH2N), 3.92 (d, J 8.4, 1H,
HCSePh), 4.61 (dd, J 8.1, 1.6, 1H, CHCH2CH2CH2N), 5.33 (m,
1H, CHCH3), 5.92 (s, 1H, NH), 7.05 (s, 1H, NH) and 7.28–7.65
(m, 5H, Ph); δC(CDCl3) 18.65, 21.38, 25.30, 27.76, 47.91, 50.26,
61.13, 71.30, 125.16, 129.77, 136.18, 138.83, 174.52 and 178.02.
(S)-N-(â-Methylcrotonyl)prolinamide 14. This compound
was analogously prepared as described for 1. Mp 151–153 ЊC;
[α]D Ϫ209.82 (c 0.79, CHCl3); RF 0.1 (silica, ethyl acetate);
δH(CDCl3) 1.82 (s, 3H, CH3), 1.89 (s, 3H, CH3), 1.86–1.99 (m,
3H, CHCH2CH2N), 2.34 (m, 1H, CHCH2CH2N), 3.54 (m, 2H,
CH2N), 4.63 (dd, J 5.5, 2.5, 1H, CHCH2CH2CH2N) and 5.85 [s,
Mp 110–111 ЊC; [α]D Ϫ59.43 (c 0.655, CHCl3); RF 0.56 (silica,
ethyl acetate); λmax(MeOH)/nm 212 and 274; νmax(film)/cmϪ1
2935, 1756, 1673, 1458, 1373, 1194 and 742; δH(CDCl3) 1.60 (d,
J 7.2, 3H, CH3), 1.84 (m, 1H, CHCH2N), 1.96–2.10 (m,
2H, CHCH2CH2N ϩ CHCH2N), 2.45 (m, 1H, CHCH2CH2N),
3.41 (ddd, J 11.8, 9.1, 2.6, 1H, CHHN), 3.59–3.70 (m, 2H,
CHCH3 ϩ one of CHHN), 4.33 (dd, J 9.7, 6.7, 1H, CHCH2-
CH2CH2N), 4.89 [d, J 5.9, 1H, C(O)CHNH], 7.26–7.64 (m, 5H,
Ph); δC(CDCl3) 18.95, 22.28, 30.35, 41.19, 45.88, 57.53, 84.94,
128.75, 129.64, 135.19, 135.57, 162.78 and 167.53.
(3S,9aS)-3-[(1ЈS)-1Ј-Phenylselenoethyl]-3-methyloctahydro-
pyrrolo[1,2-a][1,4]diazepine-1,5-dione 9
Mp 139–140 ЊC; [α]D Ϫ221.77 (c 0.82, CHCl3); RF 0.56 (silica,
ethyl acetate); λmax(MeOH)/nm 208 and 268; νmax(film)/cmϪ1
2391, 1766, 1682, 1448, 1265 and 740; δH(CDCl3) 1.52 (d, J 7.1,
3H, CH3), 1.91 (m, 1H, CHCH2N), 2.03 (m, 1H, CHCH2N),
2.26 (m, 1H, CHCH2CH2N), 2.38 (m, 1H, CHCH2CH2N), 3.59
(m, 2H, CH2N), 3.99 (dq, J 7.1, 2.4, 1H, CHCH3), 4.20 (t, J 8.0,
1H, CHCH2CH2CH2N), 4.93 [d, J 2.4, 1H, C(O)CHNH] and
7.26–7.62 (m, 5H, Ph); δC(CDCl3) 16.62, 23.41, 28.79, 37.67,
45.61, 58.09, 81.80, 128.37, 129.64, 135.18, 163.77 and 168.80;
m/z (FAB) 339 (Mϩ ϩ 1).
1H, CH᎐C(CH ) ].
᎐
3 2
Cyclofunctionalization of (S)-N-(â-methylcrotonyl)prolin-
amide 14. To a solution of (S)-N-β-methylcrotonoyl)prolin-
amide 14 (398 mg, 2.0 mmol) in acetonitrile (15 ml) were added
silver trifluoromethanesulfonate (1.04 g, 4.0 mmol) in aceto-
nitrile (12 ml), and then benzeneselenyl bromide (0.85 g, 3.6
mmol) and dimethylformamide (3.1 ml, 40 mmol) in aceto-
nitrile (12 ml). The resulting mixture was stirred at ambient
temperature for 12 h, after which it was treated with saturated
aqueous NaHCO3, and extracted with methylene dichloride.
The extract was washed with brine, dried and evaporated to
give the crude product, column chromatography of which
afforded 15 (157.2 mg, 22.4%) as a yellow solid and 16 (364.8
mg, 49.4%) and 17 (98.6 mg, 13.3%) as colourless oils.
(S)-N-(3-Hydroxy-2-phenylselenobutanoyl)prolinamide 10
Mp 119–122 ЊC; [α]D Ϫ108.68 (c 0.85, CHCl3); RF 0.06 (silica,
ethyl acetate); νmax(film)/cmϪ1 3360, 3200, 2972, 2877, 1678,
1628, 1431 and 740; δH(CDCl3) 1.39 (d, J 6.3, 3H, CH3), 1.86–
1.99 (m, 3H, CHCH2CH2N), 2.13 (m, 1H, CHCH2CH2N), 3.27
(dd, J 16.8, 7.5, 1H, CHHN), 3.63 (m, 1H, CHHN), 3.78 (d,
J 8.2, 1H, HCSePh), 4.25 (dq, J 8.2, 6.3, 1H, CHCH3), 4.38 (dd,
(9aS)-3,3-Dimethyl-4-phenylselenooctahydropyrrolo[1,2-a]-
[1,4]diazepine-1,5-dione 15. Mp 190–191.5 ЊC; [α]D Ϫ14.54 (c
1.00, CHCl3); RF 0.77 (silica, MeOH–CH2Cl2, 1:10); νmax
-
(film)/cmϪ1 1649, 1437 and 735; δH(CDCl3) 1.27 (s, 3H, CH3),
974
J. Chem. Soc., Perkin Trans. 1, 1998